✦ LIBER ✦

Optimum chemotherapy regimen for early breast cancer

✍ Scribed by Michele De Laurentiis

Book ID: 117785672
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 186 KB
Volume: 12
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(11)70125-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimum anthracycline-based chemotherapy

Optimum anthracycline-based chemotherapy for early breast cancer

✍ Julian W Adlard; David J Dodwell 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 312 KB

Adjuvant chemotherapy for early Breast C

Adjuvant chemotherapy for early Breast Cancer

✍ Yuichi Takatsuka; Takeshi Tominaga 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 293 KB

Adjuvant chemotherapy for early breast c

Adjuvant chemotherapy for early breast cancer

✍ Henderson, IC 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 664 KB

Adjuvant Chemotherapy in Early Breast Ca

Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing Regimens

✍ Giorgio Cocconi 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 83 KB

Primary/Neoadjuvant Chemotherapy for Ear

Primary/Neoadjuvant Chemotherapy for Early Breast Cancer

✍ Ian E. Smith 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB

Combination chemotherapy for advanced br

Combination chemotherapy for advanced breast cancer. Two regimens containing adriamycin

✍ Gerard T. Kennealey; Barry Boston; Malcolm S. Mitchell; Mary Kathryn Knobf; Samu 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Forty-eight women with advanced metastatic carcinoma of the breast were treated with one of two combination chemotherapy regimens: 1) adriamycin and cyclophosphamide or 2) adriamycin, cyclophosphamide, methotrexate and 5-fluorouracil. The response rate in the two-drug treatment group was 50% and in